Neurogenic Bladder and Urologic Reconstruction Quality of Life as Reported by Patient

Overview

About this study

A Study to evaluate both surgical and medical management of neurogenic bladder with longitudinally collected patient reported outcome measures. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Neurogenic bladder diagnosis.
  • ≥ 18 years old.
  • Non-neurogenic bladder patients undergoing key surgical procedures (urinary diversion, bladder augmentation, creation of catheterizable channel, urethral reconstruction, ureteric reconstruction).

Exclusion Criteria:

  •  < 18 years old.
  •  No Neurogenic bladder diagnosis or non-neurogenic bladder patients not undergoing key surgical procedures (urinary diversion, bladder augmentation, creation of a catheterizabel channel, urethral reconstruction, ureteric reconstruction).

Eligibility last updated 4/29/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Katherine Anderson, M.D.

Open for enrollment

Contact information:

Katherine Anderson M.D.

(507) 284-4015

Theisen.Katherine@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20544759

Mayo Clinic Footer